IFN-α2b increases interleukin-10 expression in primary activated human CD8+ T cells

Journal of Interferon and Cytokine Research

Volumn 22, Issue 12, 2002, Pages 1167-1173

  Curreli, Sabrina ^a   Romerio, Fabio ^a   Secchiero, Paola ^a,b   Zella, Davide ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY CD3; CD3 ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INTERFERON PRODUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; DRUG EFFECT; GENETICS; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; REFERENCE VALUE;

ANTIGENS, CD; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; INTERFERON ALFA-2B; INTERLEUKIN-10; KINETICS; LYMPHOCYTE ACTIVATION; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036975119     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900260475678     Document Type: Article

References (35)

1. DE WAAL MALEFYT, R., HAANEN, J., SPITS, H., RONCAROLO, M.G., TE VELDE, A., FIGDOR, C., JOHNSON, K., KASTELEIN, R., YSSEL, H., and DE VRIES, J.E. (1991). IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174, 915-925.
2. FIORENTINO, D.F., ZLOTNIK, A., VIERA, P., MOSMANN, T.R., HOWARD, M., MOORE, K.W., and O'GARRA, A. (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451.
3. DING, L., and SHEVACH, E.M. (1992). IL-10 inhibits mitogen-induced T-cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148, 3133-3139.
4. HSU, D.-H., MOORE, K.W., and SPITS, H. (1992). Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4, 563-569.
5. BOGDAN, C., VODOVOTZ, Y., and NATHAN, C. (1991). Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
6. DE WAAL MALEFYT, R., ABRAMS, J., BENNET, B., FIGDOR, C., and DE VRIES, J. (1991). IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
7. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M.H., and O'GARRA, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
8. DING, L., LINSEY, P.S., HUANG, L.-Y., GERMAIN, R.N., and SHEVACH, E.M. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224-1234.
9. GAZZINELLI, R.T., OSWALD, I.P., JAMES, S.L., and SHER, A. (1992). IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J. Immunol. 148, 1792-1796.
10. OSWALD, I.P., GAZZINELLI, R.T., SHER, A., and JAMES, S.L. (1992). IL-10 synergized with IL-4 TGF-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148, 3578-3582.
11. RALPH, P., NAKOINZ, I., SAMPSON-JOHANNES, A., FONG, S., LOWE, D., MIN, H.-Y., and LIN, L. (1992). IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol. 148, 808-814.
12. + T cell clones and resting T cells. J. Immunol. 150, 4754-4765.
13. MOORE, K.M., DE WAAL MALEFYT, R., COFFMAN, R.L., and O'GARRA, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
14. ISAACS, A., and LINDENMANN, J. (1957). Virus interference. I. The interferon. Proc. R. Soc. London [Ser. B.] 147, 258-274.
15. PFEFFER, L.M., DINARELLO, C.A., HERBERMAN, R.B., WILLIAMS, B.R., BORDEN, E.C., BORDENS, R., WALTER, M.R., NAGABHUSHAN, T.L., TROTTA, P.P., and PESTKA, S. (1998). Biological properties of recombinant α-interferon: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489-2499.
16. KLIMPEL, G.R., INFANTE, A.J., PATTERSON, J., HESS, C.B., and ASUNCION, M. (1990). Virus-induced interferon-α/β (IFN-α/β) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-α versus IFN-α/β on functions of different T cell populations. Cell. Immunol. 128, 603-618.
17. KRISHNASWAMY, G., SMITH, J.K., SRIKANTH, S., CHI, D.S., KALBFLEISCH, J.H., and HUANG, S.K. (1996). Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J. Interferon Cytokine Res. 16, 819-827.
18. HERBERMAN, R.B. (1997). Effect of α-interferon on immune function. Semin. Oncol. 24, (Suppl. 9), 78-80.
19. GUTTERMAN, J.U. (1994). Cytokine therapeutics: lessons from interferon. Proc. Natl. Acad. Sci. USA 91, 1198-1205.
20. BORDEN, E.C. (1997). Interferons: In: Cancer Medicine. J.F. Holland, E. Frei III, J.R. Bast, D.W. Kufe, D.L. Morton, and R.R. Weichselbaum (eds.) Baltimore: Williams & Wilkins, pp. 1199-1212.
21. DARNELL, J.E., Jr. (1997). Stats and gene regulation. Science 277, 1630-1632.
22. ROMAGNANI, S. (1992). Induction of TH1 and TH2 responses: a key role for the "natural" immune response? Immunol. Today 13, 379-381.
23. + T cells. J. Exp. Med. 178, 1655-1663.
24. + T cell recruitment into tissue. J. Immunol. 153, 1264-1270.
25. MANETTI, R., ANNUNZIATO, F., TOMASEVIC, L., GIANNO, V., PARRONCHI, P., ROMAGNANI, S., and MAGGI, E. (1995). Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur. J. Immunol. 25, 2656-2660.
26. + T cells. J. Clin. Invest. 97, 309-315.
27. + T cells and monocytes. Blood 87, 4731-4736.
28. VUKMANOVIC-STEJIC, M., VYAS, B., GORAK-STOLINSKA, P., NOBLE, A., and KEMENY, D.M. (2000). Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 95, 231-240.
29. CROFT, M., CARTER, L., SWAIN, S.L., and DUTTON, R.W. (1994). Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180, 1715-1728.
30. SAD, S., and MOSMANN, T.R. (1994). Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153, 3514-3522.
31. - cells that make Th2 cytokines and help B cells. Science 260, 1802-1805.
32. RUBINSTEIN, S., FAMILLETTI, P.C., and PESTKA, S. (1981). Convenient assay for interferons. J. Virol. 37, 755-758.
33. + T cells. J. Immunol. 164, 2296-2302.
34. AMAN, M.J., RUDOLF, G., GOLDSCHMITT, J., AULITZKY, W.E., LAM, C., HUBER, C., and PRESCHEL, C. (1993). Type I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82, 2371-2378.
35. + T Cells. Blood 89, 1110-1111.